American Journal of Kidney Diseases
Volume 51, Issue 1 , Pages 29-37 , January 2008

Risk Factors for Development and Progression of Diabetic Kidney Disease and Treatment Patterns Among Diabetic Siblings of Patients With Diabetic Kidney Disease

  • Anthony J. Bleyer, MD, MS

      Affiliations

    • Section on Nephrology, Wake Forest University School of Medicine, Winston Salem, NC
    • Corresponding Author InformationAddress correspondence to Anthony J. Bleyer, MD, MS, Section on Nephrology, Wake Forest University School of Medicine, Medical Center Blvd, Winston Salem, NC 27106.
    • ,
  • John R. Sedor, MD

      Affiliations

    • Department of Medicine, Rammelkamp Center for Research and Education, Case Western Reserve University School of Medicine, Cleveland, OH
    • ,
  • Barry I. Freedman, MD

      Affiliations

    • Section on Nephrology, Wake Forest University School of Medicine, Winston Salem, NC
    • ,
  • Alicia O’Brien, RN

      Affiliations

    • Department of Medicine, Rammelkamp Center for Research and Education, Case Western Reserve University School of Medicine, Cleveland, OH
    • ,
  • Gregory B. Russell, MS

      Affiliations

    • Section on Biostatistics, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, NC.
    • ,
  • Joni Graley, RN

      Affiliations

    • Section on Nephrology, Wake Forest University School of Medicine, Winston Salem, NC
    • ,
  • Jeffrey R. Schelling, MD

      Affiliations

    • Department of Medicine, Rammelkamp Center for Research and Education, Case Western Reserve University School of Medicine, Cleveland, OH

Received 9 May 2007 ,Accepted 5 October 2007.

References 

  1. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29:1263–1268
  2. US Renal Data System: D.6 ESRD prevalence, in USRDS 2005 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2006 pp 369-396
  3. Satko SG, Langefeld C, Daeihagh P, et al. Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy. Am J Kidney Dis. 2002;40:489–494
  4. Covic AMC, Iyengar SK, Olson JM, et al. A family-based strategy to identify genes for diabetic nephropathy. Am J Kidney Dis. 2001;37:638–647
  5. Ferguson R, Grim CE, Opgenorth TJ. A familial risk of chronic renal failure among blacks on dialysis?. J Clin Epidemiol. 1988;41:1189–1196
  6. Seaquist ER, Goetz FC, Rich S, et al. Familial clustering of diabetic kidney disease (Evidence for genetic susceptibility to diabetic nephropathy). N Engl J Med. 1989;320:1161–1165
  7. Borch-Johnsen K, Norgaard K, Hommel E, et al. Is diabetic nephropathy an inherited complication?. Kidney Int. 1992;1992:719–722
  8. Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis. 1995;25:710–713
  9. Freedman BI, Spray BJ, Tuttle AB, et al. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis. 1993;21:387–393
  10. Bergman S, Key BO, Kirk KA, et al. Kidney disease in the first-degree relatives of African Americans with hypertensive end-stage renal disease. Am J Kidney Dis. 1996;27:341–346
  11. Quinn M, Angelico MC, Warram JH, et al. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 1996;39:940–945
  12. Rostand SG, Kirk KA, Rutsky EA, et al. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med. 1982;306:1276–1279
  13. Goldschmid MG, Domin WS, Ziemer DC, et al. Diabetes in urban African Americans (II. High prevalence of microalbuminuria and nephropathy in African Americans with diabetes). Diabetes Care. 1995;18:955–961
  14. Dasmahapatra A, Bale A, Raghuwanshi MP, et al. Incipient and overt diabetic nephropathy in African Americans with NIDDM. Diabetes Care. 1994;17:297–304
  15. Chaiken RL, Khawaja R, Bard M, et al. Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects. Diabetes Care. 1997;20:709–713
  16. Chaiken RL, Palmisano J, Norton ME, et al. Interaction of hypertension and diabetes on renal function in black NIDDM subjects. Kidney Int. 1995;47:1697–1702
  17. Ritz E, Dikow R. Hypertension and antihypertensive treatment of diabetic nephropathy. Nat Clin Pract Nephrol. 2006;2:562–567
  18. de Boer IH, Sibley SD, Kestenbaum B, et al. Central obesity, incident microalbuminuria, and change in creatinine clearance in the Epidemiology of Diabetes Interventions and Complications Study. J Am Soc Nephrol. 2007;18:235–243
  19. Saiki A, Nayagama D, Ohhira M, et al. Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int J Obes. 2005;29:1115–1120
  20. Knowler WC, Coresh J, Elston RC, et al. The Family Investigation of Nephropathy and Diabetes (FIND): Design and methods. J Diabetes Complications. 2003;19:1–9
  21. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197
  22. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med. 1999;130:461–470
  23. Berman BA, Grosser SC, Gritz ER. Recruitment to a school-based adult smoking-cessation program: Do gender and race/ethnicity make a difference?. J Cancer Educ. 1998;13:220–225
  24. Woods MN, Harris KJ, Mayo MS, et al. Participation of African Americans in a smoking cessation trial: A quantitative and qualitative study. J Natl Med Assoc. 2002;94:609–618
  25. Jurkovitz C, Franch H, Shobam D, et al. Family members of patients treated for ESRD have high rates of undetected kidney disease. Am J Kidney Dis. 2002;40:1173–1178
  26. Harris MI, Klein R, Welborn TA, et al. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care. 1992;15:815–819
  27. Bryson CL, Ross HJ, Boyko EJ, et al. Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: Associations with diabetes and level of CKD. Am J Kidney Dis. 2006;46:720–726
  28. Sedor JR. Can we predict who will get sick?. J Am Soc Nephrol. 2006;17:336–338
  29. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986
  30. Boright AP, Paterson AD, Mirea L, et al. Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes. Diabetes. 2005;54:1238–1244

PII: S0272-6386(07)01370-4

doi: 10.1053/j.ajkd.2007.10.029

American Journal of Kidney Diseases
Volume 51, Issue 1 , Pages 29-37 , January 2008

Article Tools

* Image Usage & Resolution